StockData
International Stem Cell CORP logo

International Stem Cell CORP (ISCO) stock

ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.28+0.00 (+0.89%)

Close on Oct 19, 2026Market cap $2.27MP/E –Yield –

International Stem Cell operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

International Stem Cell's operating cash flow for the twelve months ending Jun 30, 2026 was $369.00K, up 235.5% year over year. For fiscal 2025 it was $8.00K, down 38.5% from the year before. The highest annual figure on record is $929.00K in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.00K-38.5%
FY2024Dec 31, 2024$13.00K-98.6%
FY2023Dec 31, 2023$929.00K+179.8%
FY2022Dec 31, 2022$332.00K–
FY2021Dec 31, 2021-$1.30M–
FY2020Dec 31, 2020-$341.00K–
FY2019Dec 31, 2019-$1.40M–
FY2018Dec 31, 2018-$1.08M–
FY2017Dec 31, 2017-$2.14M–
FY2016Dec 31, 2016-$4.20M–
FY2015Dec 31, 2015-$4.12M–
FY2014Dec 31, 2014-$6.42M–
FY2013Dec 31, 2013-$5.64M–
FY2012Dec 31, 2012-$6.69M–
FY2011Dec 31, 2011-$6.96M–
FY2010Dec 31, 2010-$6.95M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$167.00K–
Q1 FY2026Mar 31, 2026$121.00K-46.7%
Q4 FY2025Dec 31, 2025$32.00K–
Q3 FY2025Sep 30, 2025$49.00K-80.9%
Q2 FY2025Jun 30, 2025-$300.00K-1404.3%
Q1 FY2025Mar 31, 2025$227.00K–
Q4 FY2024Dec 31, 2024-$74.00K-146.0%
Q3 FY2024Sep 30, 2024$257.00K+314.5%
Q2 FY2024Jun 30, 2024$23.00K-95.3%
Q1 FY2024Mar 31, 2024-$193.00K-189.4%
Q4 FY2023Dec 31, 2023$161.00K+103.8%
Q3 FY2023Sep 30, 2023$62.00K-26.2%
Q2 FY2023Jun 30, 2023$490.00K+155.2%
Q1 FY2023Mar 31, 2023$216.00K–
Q4 FY2022Dec 31, 2022$79.00K–
Q3 FY2022Sep 30, 2022$84.00K–
Q2 FY2022Jun 30, 2022$192.00K–
Q1 FY2022Mar 31, 2022-$23.00K–
Q2 FY2021Jun 30, 2021-$363.00K–
Q1 FY2021Mar 31, 2021-$394.00K-248.7%
Q4 FY2020Dec 31, 2020-$311.00K–
Q3 FY2020Sep 30, 2020-$277.00K–
Q2 FY2020Jun 30, 2020-$18.00K–
Q1 FY2020Mar 31, 2020$265.00K–
Q4 FY2019Dec 31, 2019-$381.00K-1220.6%
Q3 FY2019Sep 30, 2019-$27.00K–
Q2 FY2019Jun 30, 2019-$648.00K–
Q1 FY2019Mar 31, 2019-$341.00K–
Q4 FY2018Dec 31, 2018$34.00K–
Q3 FY2018Sep 30, 2018-$558.00K–
Q2 FY2018Jun 30, 2018-$510.00K–
Q1 FY2018Mar 31, 2018-$48.00K–
Q4 FY2017Dec 31, 2017-$493.00K–
Q3 FY2017Sep 30, 2017-$319.00K–
Q2 FY2017Jun 30, 2017-$759.00K–
Q1 FY2017Mar 31, 2017-$571.00K–
Q4 FY2016Dec 31, 2016-$939.00K–
Q3 FY2016Sep 30, 2016-$426.00K–
Q2 FY2016Jun 30, 2016-$863.00K–

More International Stem Cell figures

See a number that looks wrong?